Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Feature
Nature Biotechnology 23, 1079–1080 (1 September 2005) | doi:10.1038/nbt0905-1079
The patentability of antibodies in the United States
&
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
